The Sloane Project is the largest prospective audit of ductal carcinoma in situ (DCIS) worldwide, with over 12000 patients registered between 2003 and 2012, accounting for 50% of screen-detected DCIS diagnosed in the UK over the period of accrual. Methods Complete mutidisciplinary data from 8313 patients with screen-detected DCIS were analysed for surgical outcome in relation to key radiological and pathological parameters for the cohort and also by hospital of treatment. Adverse surgical outcomes were defined as either failed breast conservation surgery (BCS) or mastectomy for small lesions (<20mm) (MFSL). Inter-hospital variation was analysed by grouping hospitals into high, medium and low frequency for these two adverse outcomes. Results Patients with failed BCS or MFSL together accounted for 49% of all mastectomies. Of 6633 patients embarking on BCS, 799 (12.0%) required mastectomy. MFSL accounted for 510 (21%) of 2479 mastectomy patients. Failed BCS was associated with significant radiological under-estimation of disease extent and MFSL significant radiological over-estimation of disease extent. There was considerable and significant inter-hospital variation in failed BCS (range 3-32%) and MFSL (0-60% ) of a hospital's BCS/mastectomy workload respectively. Conversely, there were no differences between the key radiological and pathological parameters in high, medium and low frequency adverse-outcome hospitals. Conclusions This evidence suggests significant practice variation, not patient factors, is responsible for these adverse surgical outcomes in screen-detected DCIS. The Sloane Project provides an evidence base for future practice benchmarking . Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast.
I should be grateful if you would consider the attached manuscript for publication in the European Journal of Cancer. This is a resubmission following appeal (previous manuscript No EJC-D-13-01702) after we had gathered additional data on hospital to hospital variation in outcomes.
We believe our study makes the following important observations on current breast screening practice and has wider implications for other multi-institution studies such as clinical trials:
1. We have quantified adverse surgical outcomes in screen-detected DCIS examining data from more than 8,000 patients -this has never been done before.
2. Having looked at a range of variables we have identified radiology/pathology size mismatch as the likely culprit at the root of these adverse outcomes.
3. There is a wide and significant variation among hospitals in the frequency of these outcomes but the case mix (as deduced by looking at the same variables again) is the same. 4 . We conclude that it is likely that practice variation is at the heart of the problem and that we can learn from the best.
Our study provides an evidence base for benchmarking future practice in this area.
The study relies heavily on statistical analysis, particularly comparison of agreement between two methods of measurement (radiology and pathology) and analysis of variation among hospitals. We have used Altman Bland difference plots and one tailed Anova testing respectively for these. The inter-hospital analysis was restricted to the top quartile of hospitals submitting cases (in terms of numbers of cases registered for the Audit) however this quartile accounts for 80% of the patients in the audit. We have also explored whether the same hospitals perform similarly for a variety of measured outputs i.e. is a hospital equally bad at one area of practice as another or are hospitals good at some areas of practice and bad at others? We have tested this by comparing rates of hospital's various outputs. There was only one significant finding here -hospitals with high overall mastectomy rates also have higher failed breast conservation rates.
We have included an Appendix giving a fuller explanation of these methods. for 50% of screen-detected DCIS diagnosed in the UK over the period of accrual.
Methods
Complete mutidisciplinary data from 8313 patients with screen-detected DCIS were analysed for surgical outcome in relation to key radiological and pathological parameters for the cohort and also by hospital of treatment. Adverse surgical outcomes were defined as either failed breast conservation surgery (BCS) or mastectomy for small lesions (<20mm) (MFSL). Inter-hospital variation was analysed by grouping hospitals into high, medium and low frequency for these two adverse outcomes.
Results
Patients with failed BCS or MFSL together accounted for 49% of all mastectomies.
Of 6633 patients embarking on BCS, 799 (12.0%) required mastectomy. MFSL accounted for 510 (21%) of 2479 mastectomy patients. Failed BCS was associated with significant radiological under-estimation of disease extent and MFSL significant radiological over-estimation of disease extent. There was considerable and significant inter-hospital variation in failed BCS (range 3-32%) and MFSL (0-60% ) of a hospital's BCS/mastectomy workload respectively. Conversely, there were no EJC 140114.doc 4 differences between the key radiological and pathological parameters in high, medium and low frequency adverse-outcome hospitals.
Conclusions
This evidence suggests significant practice variation, not patient factors, is responsible for these adverse surgical outcomes in screen-detected DCIS. The Sloane Project provides an evidence base for future practice benchmarking .
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INTRODUCTION
The recent Independent Breast Screening Review in England [1, 2] recommended improving screening and pathology techniques in the diagnosis of breast cancer and made specific reference to the The Sloane Project, a prospective UK audit of patients with screen-detected non-invasive carcinomas and atypical hyperplasias of the breast detected by the National Health Service Breast Screening Programme (NHS BSP), named in memory of the late Professor John Sloane. [3] We have identified four main clinically relevant surgical outcomes in the treatment of DCIS: successful conservation, failed conservation, mastectomy for lesions <20mm
and mastectomy for lesions ≥20mm and we have defined failed breast conservation surgery (BCS) and mastectomy for small lesions (MFSL) as adverse surgical outcomes. In the management of DCIS, precise imaging, primarily through mammographic assessment of microcalcifications, including nature, location and extent, combined with careful multidisciplinary discussion of each patient is critical in planning appropriate surgery. The three most important features for disease behaviour, and thus clinical management, are: lesion size, cytonuclear grade (grade) and width of tumour-free margins. Some randomised clinical trials have indicated that additional features may predict local recurrence, such as the architectural pattern of DCIS and the presence of necrosis. [4] [5] [6] .
We have previously shown that pathologists assess the extent of DCIS accurately in specimens from breast conserving surgery (BCS) but less so in mastectomies. [7] Using this same methodology with a much larger dataset, we have now studied the EJC is shown in Figure 1 . There was no difference in the accrual profile of operative subgroups in comparison to the overall accrual profile over time.
Completeness of data
A four-specialty dataset is available for 8313 (66%) of the 12623 patients. Data were near-complete following data cleaning. For example, the Altman Bland analysis of the 3946 patients in the single operation BCS group had radiological and pathological size measurements for 3894 patients (98.6%). The size and/or grade were recorded for 8233 (99%) cases. The lowest levels of completeness applied to ER measurements (54%); ER is not mandated in the UK DCIS pathology minimum dataset.
Surgery, extent of disease, grade, and pathological/radiological size correlations for the different operation types
The data relating to operation type are summarised in Table 1 There were 510 (21%) mastectomies for patients with disease histopathologically measuring <20mm. This could not be explained either by the location within the breast (11.3% of these were retroareolar vs 11.1% for mastectomy overall).
Mastectomy weight for specimens with DCIS lesions <20mm was lower than for for The Altman Bland bias was calculated for each operative subgroup for those specimens where specimen slice radiography had been carried out. There was no significant difference between those cases where slice radiography had been employed and those where it had not.
Mammographic calcification
There was no difference in frequency or pattern of mammographic calcification in the operative subgroups.
Inter-hospital variation: case numbers, operation type and reported grade
There was a wide range in the number of cases submitted by the 218 different hospitals. The median number of patients was 10 (range 1 -387; top quartile 50-387 in 57 hospitals). These 57 hospitals accounted for 6691 of the 8313 (80%) of the patients in the study.
Inter-hospital variation -the top quartile (57 hospitals):
The proportions of the different operation types varied substantially between hospitals. Mastectomy rates ranged from 14-65% and for failed BCS and MFSL the ranges were 3-32% and 0-60% respectively (shown in 2. Inter-hospital variation -the top quartile of hospitals analysed as three frequency subgroups (high, medium and low) for the two adverse outcomes:
The top quartile of 57 hospitals was compared in 3 groups of high, medium and low frequency (19 each). The differences in mean frequency for each 19-hospital subgroup both for failed BCS and MFSL (high v medium, medium v low, high v low)
were all highly significant (chi squared test; p=<0.0001). Analysis of the principal demographic, pathological and radiological variables (including Altman Bland bias)
for each of the frequency groups showed no significant differences. (Table 3 surgery on occasion may be inevitable. Likewise it is hard to envisage a service when mastectomy was never carried out for a small lesion, although for one of the study hospitals this was the case.
Although nearly 90% of DCIS patients treated with BCS achieved successful breast conservation, usually after a single operation, the group of patients with failed BCS comprises one third of all patients who undergo mastectomy in this study. Conversely, a sizeable subset (21%) of patients undergoing mastectomy had lesions <20mm.
Although these latter patients had smaller breasts (median 570 vs 626gm) than the large-lesion mastectomy subgroup, substantial over-estimation of the disease extent appears to drive decision-making, particularly given the range of mastectomy rates.
Furthermore, specimen weight and lesion location considerations cannot account for variation by hospital.
Data Quality
Central review of Sloane Project pathology has not been performed. The audit, however, represents the reality of current quality-assured NHS BSP pathology practice in the UK. The NHS BSP has strict audit protocols and outputs are closely EJC 140114.doc 15 monitored and published annually. The very large number of patients, even in subgroup analysis, allows important messages to emerge. Our ability to band hospitals by frequency of adverse outcome also allows us to eliminate much of the "noise" of inter-hospital variability for single data items.
Variation in practice among hospitals
The wide variation in mastectomy rates and the positive correlation with failed BCS is concerning. While patient choice may be a factor, it is unlikely to explain completely the substantial differences seen between hospitals. Data from the NHS BSP indicate that patient choice accounts for just 11% of mastectomies for DCIS. [9] The considerable variation in use of mastectomy for DCIS in different hospitals gives an opportunity to identify best practice and set criteria and measurable standards for the future. DCIS represents 20.3% of screen-detected breast cancer and addressing surgical adverse outcomes for this disease has the potential of significantly reducing screening-related morbidity. Early in the Sloane Project, the variation in practice relating to oestrogen receptor (ER) assessment and specimen handling was described. [10, 7] The finding that the accrual profile of the different operative subgroups is the same as the overall accrual profile for the audit demonstrates that there has been no change in the various operative outcomes over time and that adverse surgical outcomes are not simply a historic problem. The pre-operative multidisciplinary review meeting should recommend the most appropriate surgical procedure for each patient. These data indicate that in a proportion of women this decision was inappropriate, at least in retrospect. Since there were no appreciable differences in the case-mix in high, medium and low frequency hospital subgroups for these adverse outcomes it suggests that the multidisciplinary discussion could be more critical, with detailed appraisal of both the radiological analysis of calcification-morphology combined with pathological EJC 140114.doc 17 analysis of calcification-type seen in the pre-operative core biopsy sample.
Specifically, there is an opportunity to drill down on the detailed association of the calcification with the histology, for example regarding whether microcalcification is also present in adjacent benign lesions, and assessment as to how much DCIS is not calcified histologically. To minimise inappropriate mastectomy for small lesions the threshold for mapping the lesion extent with more than one biopsy should be considered where mastectomy is proposed based on radiological findings.
MRI is not routinely used for the pre-operative assessment of DCIS. While MRI is more accurate than mammography in high grade disease, beneficial effects on outcomes have not been demonstrated. [11, 12] Further research is needed in this area to optimise techniques and define specific patient groups that may benefit.
Conclusion
We have identified two large groups of patients -those with failed BCS and those who underwent mastectomy for small foci of DCIS -together accounting for 15% of our 8313 patient cohort, where surgical management could be improved. There is a pressing need to improve the accuracy of assessment of DCIS extent, particularly for those women where mastectomy may otherwise be indicated. In such situations, increased utilisation of multiple biopsies to accurately determine disease extent should be considered. Similarly, detailed radiological -pathological correlation of the extent and nature of the microcalcifications should be ensured at multidiscliplinary meetings.
Our data provide an evidence-base for benchmarking future practice in this area, building from the best performing hospitals to raise standards. Agreement between pathology and radiology size estimations was assessed using Altman Bland difference plots (also known as a Tukey mean-difference plot), where the difference between the radiological and pathological size for any individual is plotted against the mean of the two values. The systematic bias in any group of paired measurements is the mean of all the differences -positive or negative.
We have compared two completely unrelated measurement techniques for assessing the extent of DCIS in our patients. Radiological and pathological measurements of DCIS extent are made independently -the former at the time of initial diagnosis on the basis of the extent of a radiological abnormality (normally calcification.) and the latter from the extent of disease as measured on histological tissue sections (glass slides) from the excised tissue. The Altman Bland analysis is particularly relevant to our study population as it allows an estimate of systematic bias in any particular subgroup and the identification of outliers. It is widely used as a method in the analysis of agreement between clinical measurements.
Analysis of variation of various parameters in different hospitals
We have restricted this analysis to the top quartile of the hospitals in the audit in terms of numbers of patients entered. This is because our median value (10) is very low and our distribution has a long tail. The top quartile has a range from 387 to 50 patients and within that quartile the distribution of patients is nearly normal. We have attached sample charts of our key data groups in a supplementary Excel file to illustrate this.
We should also state that the only meaningful analysis of variance is between one subgroup and the parent group (excluding that subgroup) because one subgroups will inevitably also vary in counter-step with another. For example, if a hospital does x conservation operations then, crudely, there will be two possible outcomes: successful or unsuccessful conservation, y or x-y. It is meaningful to compare the variance of one or other of those outcomes with the variance in the parent group among different hospitals. But if one subgroup is significantly different then so will be the other.
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We have used a one tailed Anova test to compare the variance of a particular measurable among hospitals:
For the pair of data we examined (BCS parent group minus unsuccessful BCS cases v unsuccessful BCS cases) we confirmed homogeneity of variances using Hartleys F max test giving an F max value of 1.07. This is below the critical value (N=122, 2 groups, 1.15) at the 0.05 level of significance. There were significant differences in the variance of the two BCS subgroups (p=0.0001). We have supplied the descriptive analysis for the data underpinning tests including the residual plots.
The assumptions of ANOVA were met as follows:-Independence of sample groups was achieved through the selection of groups. All cases were members of only one analysis group.
The data fits well with a normal distribution. Normality was assessed by examination of the residual plots from the variance model. This indicated that the probability of a non normal distribution was <0.0001 for successful and failed BCS.
It was not possible to carry out ANOVA analysis of the by-hospital mastectomy subgroups because the case numbers were too small.
Assessment of hospitals' different operation rates.
We have used Pearson's Test to quantify the relationship between a hospital's overall mastectomy rate and its rate of failed BCS and included the output for that analysis.
We have subdivided the top quartile (57 hospitals) into three frequency groups each of 19 hospitals for failed BCS and MFSL respectively. It should be noted that there was little overlap in the frequency subgroupings for the two adverse outcomes and therefore the numbers of patients in each subgroup for each outcome are inevitably different. A chi squared test was used to test significance between the frequencies for each subgroup in an outcome group. Each frequency subgroup comprised over 1800 patients.
EJC 140114.doc 24 Legends Tables   Table 1: Disease extent (pathological), radiological/pathological size agreement, DCIS grade, ER positivity and use of slice radiography relating to operation type. Table 2 : Distribution of different operation types by submitting hospital (top quartile).
The percentages referred to in the ranges refer to breast conservation and mastectomy totals respectively, e.g mastectomy for lesions <20mm accounted for 3-60% of all mastectomies in the different hospitals. Table 3 : Data analysis for high, middle and low frequency hospitals as ranked for failed BCS and mastectomy for small tumours respectively. Table 2 : Distribution of different operation types by submitting hospital (top quartile). The percentages referred to in the ranges refer to breast conservation and m totals respectively, e.g mastectomy for lesions <20mm accounted for 3-60% of all mastectomies in the different hospitals. There were substantial differences in the percentages of the two more common patterns of DCIS (solid and cribriform), grade, comedo necrosis and ER positivity among the top quartile of treatment hospitals. There was no correlation between grade, comedo necrosis or histological pattern and a hospital's operative profile.
Figures

Extent of DCIS: Grade and ER status
There was a significant difference in the grade distribution between smaller lesions 15mm and larger lesions (T test; p=<0.0001); there was 50% more high grade disease in more extensive lesions. However, there was no significant difference in the grade distribution between 15-40mm and >40mm DCIS. 
SUPPLEMENTARY DISCUSSION
Pathological variables
A pure architectural pattern of DCIS was recorded in over half of our patients. Three main points emerge: solid pattern DCIS is very commonly high grade and associated with comedo necrosis, while cribriform DCIS is more commonly a smaller lesion and more frequently low grade. Notably, and in contrast to a previous report, we have no evidence that micropapillary DCIS is a particularly extensive or multicentric lesion. [1] Invasive breast cancer is graded by assessing three variables and consistency of grading is considered acceptable with published kappa values for overall consistency (j value) for grade 1 and grade 3 of 0.45 and 0.63, respectively. [2, 3] Consistency of grading and classifying DCIS where a single feature (cytonuclear morphology) is used is poor in comparison (Schuh et al,) . [4] Although comedo necrosis has been shown to be of prognostic significance [5] this feature is not routinely combined with the singlefeature cytonuclear grade to improve discrimination in UK practice and although assessment of the pattern of DCIS has been shown to add value to this exercise, mixed patterns are seen frequently and therefore is difficult to apply in practice. [6] A major goal of the Sloane Project is to improve prognostic assessment of DCIS and reviewing prognostic algorithms such as the Van Nuys Prognostic Index [7] will be possible as more complete recurrence data become available. Data on margin width will be of considerable interest at that time too.
